Evolution from an antecedent chronic myeloid malignancy does not impact survival outcomes in NPM1-mutated AML. Smith E, Atenafu EG, Bankar A, Chan S, et al. Eur J Haematol 2024;113:716-726.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Smith E, Atenafu EG, Bankar A, Chan S, et al. Evolution from an antecedent chronic myeloid malignancy does not impact survival outcomes in NPM1-mutated AML. Eur J Haematol 2024;113:716-726.
PMID: 39113600